The Investigational Medicinal Product Dossier (IMPD): EU's CTA vs. FDA's IND June 15, 2012

This 90 minute webinar will help you comprehensively understand the IMPD (Investigational Medicinal Product Dossier) and the structure and content differences between a EU CTA Application and an FDA IND Application.

Why Should You Attend:

All sponsors, CROs, Sites and auditors of Clinical Research who are involved in pharmaceutical or biological development need to possess the knowledge and be efficient in completing successful applications for their studies. Knowing what is expected of you and “getting-it-right” the first time, will allow faster development of innovative products.

This 90 minute training course will provide your company the opportunity for comprehensive understanding of the IMPD (Investigational Medicinal Product Dossier) and the structure and content differences between a EU CTA Application and an FDA IND Application. Additionally, this webinar covers many related processes sponsors will need to know, as they file for, conduct and close-out effective clinical studies in the U.S. and EU.

Agenda: (All time in EDT):

- 12:45 pm EDT Sign into Webinar
- 1:00 pm to 2:30 pm Course Delivery
- 2:30 to 2:45 pm (Break)
- 2:45 pm Q&A Session

Official Website: http://www.complianceonline.com/ecommerce/control/trainingFocus/~product_id=702030?channel=yahooevent